Titre :
  • Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial.
Auteur : Eggermont, A ; Suciu, Stefan ; Mackie, Rona ; Ruka, Wlodzimierz ; Testori, Alessandro ; Kruit, Wim H ; Punt, Cornelis ; Delauney, Michelle ; Sales, François ; Groenewegen, Gerard ; Ruiter, D J ; Jagiello, Izabella ; Stoitchkov, K ; Keilholz, Ulrich ; Lienard, Danielle ; EORTC Melanoma Group
Informations sur la publication : Lancet, 366, 9492, (page 1189-1196)
Statut de publication : Publié, 2005-10
Sujet CREF : Cancérologie
Mots-clés MeSH : Adult
Aged
Antineoplastic Agents -- adverse effects -- therapeutic use
Chemotherapy, Adjuvant
Combined Modality Therapy
Female
Humans
Interferon-alpha -- adverse effects -- therapeutic use
Lymphatic Metastasis
Male
Melanoma -- drug therapy -- pathology -- secondary -- surgery
Middle Aged
Recombinant Proteins
Skin Neoplasms -- drug therapy -- pathology -- surgery
Note : Clinical Trial
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
SCOPUS: ar.j
Langue :
  • Anglais
Identificateurs : urn:issn:0140-6736 
info:doi/10.1016/S0140-6736(05)67482-X
info:pii/S0140-6736(05)67482-X
info:pmid/16198768